Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.M. McCormack, M.E. Burt, M.S. Bains, et al.
Lung resection for colorectal metastases.
Arch Surg, 127 (1992), pp. 1403-1406
[2.]
S. Okumara, H. Kondo, M. Tsuboi, et al.
Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients.
J Thorac Cardiovasc Surg, 112 (1996), pp. 867-874
[3.]
T. De Giacomo, E.A. Rendina, F. Venuta, et al.
Thoracoscopic resection of solitary lung metastases from coloretal cancer is a viable therapeutic option.
Chest, 115 (1999), pp. 1441-1443
[4.]
J. Machi, H. Isomoto, T. Kuruhiji, et al.
Accuracy of intraoperative ultrasonografy in diagnosing liver metastases from colorectal cancer; evaluation with postoperative follow-up results.
World J Surg, 15 (1991), pp. 551-557
[5.]
F.D. Rahusen, M.A. Cuesta, P.J. Borgstein, et al.
Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography.
Ann Surg, 230 (1999), pp. 31-37
[6.]
E.A. Bakalakos, J.A. Kim, D.C. Young, et al.
Determinants of survival following hepatic resection for metastasic colorectal cancer.
World J Surg, 22 (1998), pp. 566-571
[7.]
H.J. Wanebo, Q.D. Chu, M.P. Vezeridis, et al.
Patient selection for hepatic resection of colorectal metastases.
Arch Surg, 131 (1996), pp. 322-329
[8.]
M. Taylor, J. Forster, B. Langer, et al.
A study of prognostic factors for hepatic resection for colorectal metastases.
Am J Surg, 173 (1997), pp. 467-471
[9.]
Y. Fong, A.M. Cohen, J.G. Fortner, et al.
Liver resection for colorectal metastases.
J Clin Oncol, 15 (1997), pp. 938-946
[10.]
S.D. Ambiru, M. Miyazaki, T. Isono, et al.
Hepatic resection for colorectal metastases.
Dis Colon Rectum, 42 (1999), pp. 632-639
[11.]
M. Minagawa, M. Makuuchi, G. Torzilli, et al.
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer.
Ann Surg, 42 (1999), pp. 632-639
[12.]
R. Doci, L. Gennari, P. Bignami, et al.
One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants.
Br J Surg, 78 (1991), pp. 797-801
[13.]
P. Hohenberger, P.M. Schlag, T. Gerneth, et al.
Pre-and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases.
Ann Surg, 217 (1994), pp. 135-143
[14.]
J. Scheele, R. Stang, A. Altendorf-Hofmann, et al.
Resection of colorectal liver metastases.
World J Surg, 19 (1995), pp. 59-71
[15.]
L.T. Jenkins, K.W. Millikan, S.D. Bines, et al.
Hepatic resection for metastasic colorectal cancer.
Am J Surg, 63 (1997), pp. 605-610
[16.]
M. Rees, G. Plant, S. Bygrave.
Late results justify resection for multiple hepatic metastases from colorectal cancer.
Br J Surg, 84 (1997), pp. 1136-1140
[17.]
C.B. Rosen, D.M. Nagorney, H.F. Taswell, et al.
Perioperative blood trasfusion and determinants of survival after liver resection for metastasic colorectal carcinoma.
Ann Surg, 216 (1992), pp. 493-504
[18.]
T.J. Gayowski, S. Iwatsuky, J.R. Madariaga, et al.
Experience in hepatic resection for metastasic colorectal cancer. Analysis of clinical and pathologic risk factors.
Surg, 116 (1994), pp. 703-711
[19.]
I.K. Pedersen, F. Burcharth, O. Roikjaer, et al.
Resection of liver metastases from colorectal cancer.
Dis Colon Rectum, 37 (1994), pp. 1078-1082
[20.]
B. Cady, R.L. Jenkins, G.D. Steele, et al.
Surgical margin in hepatic resection for colorectal metastasis.
Ann Surg, 227 (1998), pp. 566-571
[21.]
B. Ohlsson, U. Stenram, G. Tranberg.
Resection of colorectal liver metastases: 25-Year Experience.
World J Surg, 22 (1998), pp. 268-277
[22.]
D. Elias, A. Cavalcanti, J.C. Sabourin, et al.
Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases.
J Surg Oncol, 69 (1998), pp. 88-93
[23.]
K.T. Berckurts, A.H. Hölscher, S.T. Thorban, et al.
Significance of limph node involvement at the hepatic hilium in the resection of colorectal liver metastases.
Br J Surg, 84 (1997), pp. 1081-1084
[24.]
K. Yasui, T. Hirai, T. Kato, et al.
A new macroscopic classification predicts prognosis for patients with liver metastases from colorectal cancer.
Ann Surg, 226 (1997), pp. 582-586
[25.]
B. Nordlinger, M. Guiguet, J.C. Vaillant, et al.
Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1.568 patients.
Cancer, 77 (1996), pp. 1254-1262
[26.]
Y. Fong, J. Fortner, R.L. Sun, et al.
Clinical score for predicting recurrence after hepatic resection for metastasic colorectal cancer. Analysis of 1.001 consecutive cases.
Ann Surg, 230 (1999), pp. 309-321
[27.]
S. Iwatsuki, I. Dvorchik, J.R. Madariaga, et al.
Hepatic resection for metastasic colorectal adenocarcinoma: a proposal of a prognostic scoring system.
J Am Coll Surg, 189 (1999), pp. 291-299
[28.]
Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
Expentancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomised trial.
J Clin Oncol, 10 (1992), pp. 904-911
[29.]
W. Scheithhauer, H. Rosen, G.V. Kornek.
Randomized comparison of combination chemotherapy plus supportive care with suportive care alone in patients with metastasic colorectal cancer.
Br Med J, 306 (1993), pp. 752-755
[30.]
N. Kemeny, J. Daly, B. Reichman, et al.
Intrahepatic or sistemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma.
Ann Intern Med, 107 (1987), pp. 459-465
[31.]
A.E. Chang, P.D. Schneider, P.H. Sugarbaker, et al.
A prospective randomized trial of regional versus systemic continuos 5- fluorodeoxyuridine chemotherapy in the threatment of colorectal liver metastases.
Ann Surg, 206 (1987), pp. 685-693
[32.]
D. Hohn, R.J. Stagg, M.A. Friedman, et al.
A randomized trial of continuos intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastasic to the liver (Northern California Oncology group trial).
J Clin Oncol, 7 (1989), pp. 1646-1654
[33.]
L.D. Wagman, M.M. Kemeny, G. Leong, et al.
A prospective randomized evaluation of the treatment of colorectal cancer metastasic to the liver.
J Clin Oncol, 8 (1990), pp. 1885-1893
[34.]
J.K. Martin, M.J. O'Connell, H.S. Wieand, et al.
Intraarterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer.
Arch Surg, 125 (1990), pp. 1022-1027
[35.]
P. Rougier, A. Laplanche, M. Huguier, et al.
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
J Clin Oncol, 10 (1992), pp. 1112-1118
[36.]
T.G. Allen-Mersh, S. Earlam, C. Fordy, et al.
Quality of live and survival with continuous hepatic-artery fluoxuridine infusion for colorectal liver metastases.
Lancet, 344 (1994), pp. 1255-1260
[37.]
Meta-analysis Group in Cancer..
Reappraisal of hepatic artery infusion in the treatment of non-resectable liver metastases from colorectal cancer.
J Natl Cancer Inst, 88 (1996), pp. 252-258
[38.]
I. Durand-Zaleski, B. Roche, M. Byse, et al.
Meta-analysis Group in Cancer. Economic implications of hepatic arterial infusion in treatment of nonresecable colorectal liver metastases.
J Natl Cancer Inst, 89 (1997), pp. 790-795
[39.]
D.C. Hohn, A.A. Rayner, J.S. Economov, et al.
Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
Cancer, 57 (1986), pp. 465-470
[40.]
R.J. Stagg, A.P. Vennok, J.L. Chase, et al.
Alternating hepatic intraarterial FUDR and 5-FU: a less toxic regimen for treatment of liver metastases from colorectal cancer.
J Natl Cancer Inst, 8 (1991), pp. 423-428
[41.]
N. Kemeny, J.A. Conti, A. Cohen, et al.
Phase II study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresecable liver metastases from colorectal carcinoma.
J Clin Oncol, 12 (1994), pp. 2288-2295
[42.]
M. Lorenz.
Müller H-H. German Cooperative group on Liver Metastases. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus flurodeoxyuridine administered via hepatic arterial infusion in patients with nonresecable liver metastases from colorectal carcinoma.
J Clin Oncol, 18 (2000), pp. 243-254
[43.]
A. De Gramont, A. Figer, M. Seymour, et al.
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment of metastatic colorectal cancer.
J Clin Oncol, 18 (2000), pp. 2938-2947
[44.]
S. Giacchetti, B. Perpoint, R. Zidani, et al.
Phase III multicenter randomized trial of oxaliplatin added to cronomodulated fluorouracil-leucovorin as first line treatment of metastasic colorectal cancer.
J Clin Oncol, 18 (2000), pp. 136-147
[45.]
L.B. Saltz, P.K. Locker, N. Pirotta, et al.
Weekly irinotecan (CPT- 11), leucovorin (LV), and fluorouracil (FU) is superior to daily ' 5 LV/5FU in patients with previusly untreated metastasic colorectal cancer (CRC).
N Engl J Med, 343 (2000), pp. 905-914
[46.]
J.Y. Douillard, D. Cunningham, A.D. Roth, et al.
Irinotecan combined with fluorouracil compared with fluorouracil alone at firstline treatment for metastasic colorectal cancer: a multicentre randomised trial.
Lancet, 355 (2000), pp. 1041-1047
[47.]
W.C. Fowler, B.L. Eisenberg, J.P. Hoffman, et al.
Hepatic resection following systemic chemotherapy for metastasic colorectal carcinoma.
J Surg Oncol, 51 (1992), pp. 122-125
[48.]
D. Elias, P. Lasser, P. Rougier, et al.
Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intraarterial hepatic chemotherapy for initially unresecable hepatic tumors.
J Am Coll Surg, 180 (1995), pp. 213-219
[49.]
H. Bismuth, A. René, F. Lévi, et al.
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.
Ann Surg, 224 (1996), pp. 509-522
[50.]
S. Giacchetti, M. Itzhaki, G. Gruia, et al.
Long-term survival of patients with unresecable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.
Ann Oncol, 10 (1999), pp. 663-669
[51.]
S.D. Bines, A. Doolas, L. Jenkins, et al.
Survival after repeat hepatic resection for recurrent colorectal hepatic metastases.
Surgery, 120 (1996), pp. 591-596
[52.]
M. Lorenz, H-H Müller, H. Schramm, et al.
For the German Cooperative Liver Metastases. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5- fluorouracil and folinic acid for liver metastases of colorectal cancer.
Ann Surg, 228 (1998), pp. 756-762
[53.]
N. Kemeny, Y. Huang, A.M. Cohen, et al.
Hepatic arterial infusion of quemotherapy after resection of hepatic metastases from colorectal cancer.
N Engl J Med, 341 (1999), pp. 2039-2048
[54.]
M.M. Kemeny, S. Adak, S. Lipsitz, et al.
American Intergroup SWOG/ECOG. Prospective randomized study of surgery alone vs continuos hepatic artery infusion of FUDR and continuos systemic infusion of 5FU after hepatic resection for colorectal liver metastases.
Proc Am Soc Clin Oncol, 18 (1999), pp. 1012
[55.]
J.G. Armstrong, L.L. Anderson, L.B. Harrison, et al.
Treatment of liver metastases from colorectal cancer with radioactive implants.
Cancer, 73 (1994), pp. 1800-1804
[56.]
D.S. Thomas, R.J. Nauta, J.E. Rodgers, et al.
Intraoperative highdose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of phase I-II trial.
Cancer, 71 (1993), pp. 1977-1981
[57.]
A.P. Retekes, J.R. Caplehorn, J. King, et al.
Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases form colorectal carcinoma treated with cryotherapy.
World J Surg, 19 (1995), pp. 768-771
[58.]
S.N. Goldberg, G.S. Gazelle, S.L. Dawson, et al.
Tissue ablation with radiofrequency using multiprove arrays.
Acad Radiol, 2 (1995), pp. 670-674
[59.]
D. Elias, T. Debaere, I. Muttillo, et al.
Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection.
J Surg Oncol, 67 (1998), pp. 190-191
[60.]
T. Livraghi, S.N. Goldberg, F. Monti, et al.
Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastases.
Radiology, 202 (1997), pp. 205-210
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
